NEWS AND EVENTS
NEWS AND EVENTS
Sanifit Enhances Leadership Team with New Executive Appointments
Newly appointed VP of Business Development and SVP of Clinical Development each bring to Sanifit over 20 years of industry experience Palma, Spain and San Diego, USA, 01 June 2020 – Sanifit, a clinical-stage biopharmaceutical company focused on developing treatments for calcification disorders, is delighted to announce two new appointments to its Executive leadership team, […]
SNF472 featured in AHA Journal’s Circulation on the Run podcast
Dr. Paolo Raggi, Principal Investigator of Sanifit’s Phase 2b CaLIPSO study of SNF472, was recently interviewed by the American Heart Association Journal’s Circulation On The Run podcast team. You can hear Dr Raggi speak about the effect of calcification on patients with end stage renal disease, the significant outcomes of the trial and the next […]
First patient dosed in pivotal phase 3 trial of SNF472 in calciphylaxis
First patient dosed in phase 3 trial of SNF472 for the treatment of calcific uremic arteriolopathy (CUA) or calciphylaxis Palma, Spain and San Diego, USA, 13 February 2020 – Sanifit, a clinical-stage biopharmaceutical company focused on developing treatments for calcification disorders, today announced that the first patient has successfully been dosed in its pivotal […]
Positive data from Sanifit’s Phase 2b CaLIPSO trial of SNF472 published in Circulation
SNF472 significantly reduced progression of cardiovascular calcification in patients with end stage kidney disease (ESKD) receiving hemodialysis SNF472 treated patients had coronary artery calcium (CAC) volume score progression of 11% from baseline versus 20% in patients receiving placebo (P=0.016) SNF472 was well tolerated Results are remarkable as they have been achieved in patients who […]
Sanifit announces that the Phase 2b CaLIPSO trial of SNF472 met its primary endpoint in slowing the progression of cardiovascular calcification in patients on hemodialysis
Top line data to be presented at 2019 Scientific Sessions of American Heart Association Webcast to be held on Monday 18 November at 11.00 ET Palma, Spain and San Diego, USA, 30 October 2019 – Sanifit, a clinical-stage biopharmaceutical company focused on treatments for progressive vascular calcification disorders, today announced that the international Phase 2b […]
UPCOMING EVENTS
17th – 19th November– Jefferies London Healthcare Conference, London, UK.
14th – 16th November – American Heart Association Conference, Dallas, USA.
26th – 28th October – BIO Europe, Munich, Germany
20th – 25th October – ASN Kidney Week, Denver, USA
6th – 9th June – ERA-EDTA, Milan, Italy
8th – 11th June – Bio International, San Diego, USA
16th – 19th May – European Calcified Tissue Society Congress, Marseille, France
23th – 25th March – Bio Europe Spring, Paris, France
13th – 16th January – JPMorgan, San Francisco, USA